You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.
Latest Type 1 Issues Articles
Popular Type 1 Issues Articles
Highly Recommended Type 1 Issues Articles
Send a link to this page to your friends and colleagues.
The survival and success rates for pancreas transplants have improved during recent years. By 1997, almost 10,000 such transplants had been done.
According to the International Pancreas Transplant Registry, first-year graft survival rates between 1994 and 1997 were 82 percent for a simultaneous kidney-pancreas transplant, 71 percent when a pancreas was transplanted after a kidney transplantation and 62 percent when a pancreas was transplanted alone. Type 1 patients with renal failure are encouraged to have a pancreas transplant at the same time as or after a kidney transplantation, because it is easier to detect rejection by measuring the serum creatinine produced by the kidney. When successful, a pancreas-kidney transplantation can restore normal blood sugars and insulin levels for five to 20 years.
Although islet transplantations are less invasive than a pancreas transplant, they are also less successful. Data from the 1990—1995 International Islet Transplant Registry shows that only 6 percent of type 1 recipients were free from insulin shots or pumps one year after transplant. Recipients of islet, as well as organ, transplants often need to take powerful immunosuppressants for life. These drugs usually come with adverse side effects.
According to the ADA, islet cell transplantation should be considered an experimental procedure at this stage and should be performed in a controlled research setting.
Pancreas transplantations are usually recommended for people who have had type 1 diabetes for 20 or more years. Like any major surgery, the procedure is risky and also requires recipients to take powerful immunosuppressants for life. Also, transplantation has not been wholly successful in reversing long-term damage inflicted by kidney disease and neuropathy. There is no guarantee that the islet-destroying autoimmune process will cease with transplantation.
-Diabetes Care, January 2000
Categories: Blood Sugar, Diabetes, Diabetes, Insulin, Islet & Pancreas Transplant, Type 1 Issues
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.

Comments
Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.
When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.
For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.
Don't have your Diabetes Health Username? Register now and add your comments to all our content.
Register...
Register your Diabetes Health Username here.
Have Your Say...